---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-289805"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2025-11-20T23:59:59+00:00"
generated_at: "2026-05-16T18:16:51.728556+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CVS Health appoints CEO David Joyner as Chair of the Board effective Jan 1, 2026

## Summary
- Joyner, President & CEO since Oct 2024, will also serve as Board Chair starting Jan 1, 2026.
- Michael Mahoney continues as Lead Independent Director; Roger Farah remains on the Board.
- Board cites Joyner's nearly 40 years of healthcare experience and operational improvements.
- Joyner leads over 300,000 colleagues; Farah says 'bullish on future' under combined roles.

## SEC filing metadata
- accession: 0001193125-25-289805
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2025-11-20T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000119312525289805/0001193125-25-289805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000119312525289805/d172430d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-289805
- JSON: https://secwatch.observer/filing/0001193125-25-289805.json
- Plain text: https://secwatch.observer/filing/0001193125-25-289805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.